FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2790799851> ?p ?o ?g. }

• W2790799851 endingPage "1871" @default.
• W2790799851 startingPage "1866" @default.
• W2790799851 abstract "Abstract Purpose: Adverse drug reactions such as ototoxicity, which occurs in approximately one-fifth of adult patients who receive cisplatin treatment, can incur large socioeconomic burdens on patients with testicular cancer who develop this cancer during early adulthood. Recent genome-wide association studies have identified genetic variants in ACYP2 and WFS1 that are associated with cisplatin-induced ototoxicity. We sought to explore the role of these genetic susceptibility factors to cisplatin-induced ototoxicity in patients with testicular cancer. Experimental Design: Extensive clinical and demographic data were collected for 229 patients with testicular cancer treated with cisplatin. Patients were genotyped for two variants, ACYP2 rs1872328 and WFS1 rs62283056, that have previously been associated with hearing loss in cisplatin-treated patients. Analyses were performed to investigate the association of these variants with ototoxicity in this cohort of adult patients with testicular cancer. Results: Pharmacogenomic analyses revealed that ACYP2 rs1872328 was significantly associated with cisplatin-induced ototoxicity [P = 2.83 × 10−3, OR (95% CI):14.7 (2.6–84.2)]. WFS1 rs62283056 was not significantly associated with ototoxicity caused by cisplatin (P = 0.39); however, this variant was associated with hearing loss attributable to any cause [P = 5.67 × 10−3, OR (95% CI): 3.2 (1.4–7.7)]. Conclusions: This study has provided the first evidence for the role of ACYP2 rs1872328 in cisplatin-induced ototoxicity in patients with testicular cancer. These results support the use of this information to guide the development of strategies to prevent cisplatin-induced ototoxicity across cancers. Further, this study has highlighted the importance of phenotypic differences in replication studies and has provided further evidence for the role of WFS1 rs62283056 in susceptibility to hearing loss, which may be worsened by cisplatin treatment. Clin Cancer Res; 24(8); 1866–71. ©2018 AACR." @default.
• W2790799851 created "2018-03-29" @default.
• W2790799851 creator A5001731680 @default.
• W2790799851 creator A5008024031 @default.
• W2790799851 creator A5028891716 @default.
• W2790799851 creator A5039535069 @default.
• W2790799851 creator A5039848890 @default.
• W2790799851 creator A5040356803 @default.
• W2790799851 creator A5041145711 @default.
• W2790799851 creator A5047722409 @default.
• W2790799851 creator A5067468792 @default.
• W2790799851 creator A5067476303 @default.
• W2790799851 creator A5069201662 @default.
• W2790799851 creator A5077683545 @default.
• W2790799851 creator A5087150696 @default.
• W2790799851 date "2018-04-12" @default.
• W2790799851 modified "2023-10-17" @default.
• W2790799851 title "Further Investigation of the Role of <i>ACYP2</i> and <i>WFS1</i> Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients" @default.
• W2790799851 cites W1533942137 @default.
• W2790799851 cites W1545821558 @default.
• W2790799851 cites W1971983191 @default.
• W2790799851 cites W1997303937 @default.
• W2790799851 cites W2001456860 @default.
• W2790799851 cites W2055368684 @default.
• W2790799851 cites W2060784631 @default.
• W2790799851 cites W2061424770 @default.
• W2790799851 cites W2067406483 @default.
• W2790799851 cites W2077953289 @default.
• W2790799851 cites W2105748723 @default.
• W2790799851 cites W2113304916 @default.
• W2790799851 cites W2119444539 @default.
• W2790799851 cites W2157752701 @default.
• W2790799851 cites W2159764363 @default.
• W2790799851 cites W2160995259 @default.
• W2790799851 cites W2218950712 @default.
• W2790799851 cites W2267368291 @default.
• W2790799851 cites W2283420536 @default.
• W2790799851 cites W2327276257 @default.
• W2790799851 cites W2466806233 @default.
• W2790799851 cites W2563952521 @default.
• W2790799851 cites W2564575422 @default.
• W2790799851 cites W2607785336 @default.
• W2790799851 cites W2610038554 @default.
• W2790799851 cites W2620036274 @default.
• W2790799851 doi "https://doi.org/10.1158/1078-0432.ccr-17-2810" @default.
• W2790799851 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29358504" @default.
• W2790799851 hasPublicationYear "2018" @default.
• W2790799851 type Work @default.
• W2790799851 sameAs 2790799851 @default.
• W2790799851 citedByCount "29" @default.
• W2790799851 countsByYear W27907998512018 @default.
• W2790799851 countsByYear W27907998512019 @default.
• W2790799851 countsByYear W27907998512020 @default.
• W2790799851 countsByYear W27907998512021 @default.
• W2790799851 countsByYear W27907998512022 @default.
• W2790799851 countsByYear W27907998512023 @default.
• W2790799851 crossrefType "journal-article" @default.
• W2790799851 hasAuthorship W2790799851A5001731680 @default.
• W2790799851 hasAuthorship W2790799851A5008024031 @default.
• W2790799851 hasAuthorship W2790799851A5028891716 @default.
• W2790799851 hasAuthorship W2790799851A5039535069 @default.
• W2790799851 hasAuthorship W2790799851A5039848890 @default.
• W2790799851 hasAuthorship W2790799851A5040356803 @default.
• W2790799851 hasAuthorship W2790799851A5041145711 @default.
• W2790799851 hasAuthorship W2790799851A5047722409 @default.
• W2790799851 hasAuthorship W2790799851A5067468792 @default.
• W2790799851 hasAuthorship W2790799851A5067476303 @default.
• W2790799851 hasAuthorship W2790799851A5069201662 @default.
• W2790799851 hasAuthorship W2790799851A5077683545 @default.
• W2790799851 hasAuthorship W2790799851A5087150696 @default.
• W2790799851 hasBestOaLocation W27907998511 @default.
• W2790799851 hasConcept C121608353 @default.
• W2790799851 hasConcept C126322002 @default.
• W2790799851 hasConcept C143998085 @default.
• W2790799851 hasConcept C170734499 @default.
• W2790799851 hasConcept C2776212926 @default.
• W2790799851 hasConcept C2776694085 @default.
• W2790799851 hasConcept C2778239845 @default.
• W2790799851 hasConcept C2778534666 @default.
• W2790799851 hasConcept C2780493683 @default.
• W2790799851 hasConcept C548259974 @default.
• W2790799851 hasConcept C71924100 @default.
• W2790799851 hasConcept C98274493 @default.
• W2790799851 hasConceptScore W2790799851C121608353 @default.
• W2790799851 hasConceptScore W2790799851C126322002 @default.
• W2790799851 hasConceptScore W2790799851C143998085 @default.
• W2790799851 hasConceptScore W2790799851C170734499 @default.
• W2790799851 hasConceptScore W2790799851C2776212926 @default.
• W2790799851 hasConceptScore W2790799851C2776694085 @default.
• W2790799851 hasConceptScore W2790799851C2778239845 @default.
• W2790799851 hasConceptScore W2790799851C2778534666 @default.
• W2790799851 hasConceptScore W2790799851C2780493683 @default.
• W2790799851 hasConceptScore W2790799851C548259974 @default.
• W2790799851 hasConceptScore W2790799851C71924100 @default.
• W2790799851 hasConceptScore W2790799851C98274493 @default.
• W2790799851 hasFunder F4320334506 @default.
• W2790799851 hasIssue "8" @default.
• W2790799851 hasLocation W27907998511 @default.

• next